A Randomized, Open-Label Clinical Study on the Efficacy of Baloxavir Marboxil and Oseltamivir for Post-Exposure Prevention of Influenza in a Hospital Setting
Latest Information Update: 14 Jan 2025
Price :
$35 *
At a glance
- Drugs Baloxavir-marboxil (Primary) ; Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 14 Jan 2025 New trial record